Tg Therapeutics Inc (TGTX)

R&D Expenses

$225.80M

TTM · Period ending: · USD

TGTX logo

TGTX R&D Expenses

Latest reported$225.80M
TGTX TTM R&D Expenses ($900.00K → $225.80M)
High-resolution chart · PNG

TGTX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tg Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
225,804,000
162,249,000
160,215,000
142,896,000
122,156,000
107,930,000
94,290,000
87,865,000
82,480,000
87,382,000
70,530,000
82,716,000
88,764,000
93,180,000
125,352,000
158,363,000
189,529,000
207,526,000
222,578,000
202,893,000
201,390,000
192,968,000
165,896,000
152,389,000
158,428,000
153,493,000
148,367,000
169,982,000
146,233,000
152,531,000
153,794,000
128,461,101
121,041,863
108,669,340
96,886,134
92,564,756
88,108,102
75,635,199
66,489,820
58,801,023
49,461,161
46,396,801
43,445,817
42,527,395
43,480,147
37,125,954
31,354,781
22,153,662
12,800,783
13,914,217
12,621,161
9,874,998
8,297,681
5,282,320
20,808,471
19,734,240
18,269,335
16,713,459
327,283
731,585
872,422
833,203
495,793
288,722
57,562
13,207
40,376
-4,706
488,573
1,047,657
1,802,792
3,040,299
4,350,404
7,656,310
8,535,687
9,284,735
8,499,224
6,081,401
6,425,272
18,274,453
18,621,739
18,125,163
17,065,884
4,537,829
4,846,035
4,407,761
4,152,994
3,896,865
2,595,746
2,389,961
1,724,043
806,950
554,506
381,265
539,752
579,529
626,410
486,475
591,400
-1,726,820
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.